Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
06:42pm, Monday, 04'th Mar 2024
Ordinarily, you'll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound.
Here's Why Gilead Sciences (GILD) Gained But Lagged the Market Today
06:56pm, Friday, 01'st Mar 2024
In the latest trading session, Gilead Sciences (GILD) closed at $72.31, marking a +0.29% move from the previous day.
Don't Rely On Past Performance
01:15pm, Monday, 26'th Feb 2024
Rob Isbitts discusses his ROAR Score, which measures reward opportunity and risk in the market.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new clinical data and real-world evidence (RWE) from its antiviral research and
History Says the Nasdaq Will Keep Soaring in 2024 -- and Wall Street Thinks This High-Yield Dividend Stock Could Jump Nearly 20%
05:52am, Saturday, 24'th Feb 2024
Analysts have great expectations for Gilead Sciences over the next 12 months. The biotech has an attractive valuation, a juicy dividend, several drugs with solid momentum, and plenty of cash.
Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?
10:00am, Thursday, 22'nd Feb 2024
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Alert: 3 Market Giants on the Brink of Monumental Rallies
10:08am, Tuesday, 20'th Feb 2024
During stock market ups and downs, identifying the next big players breeding massive value growth potentials is similar to finding a pearl in a vast ice lake. Among the multitude of options, certain m
From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024
01:46pm, Monday, 19'th Feb 2024
Stock turnarounds can happen when you least expect it. And with the opposite scenario imposing a rude awakening, it's time to at least consider last year's losers to make big splashes in 2024.
Want $3750 in Passive Income? Invest $7500 in These 7 Stocks
10:45am, Friday, 16'th Feb 2024
Work smarter, not harder, says the adage. One way to do that is with passive income, which is derived from ownership rather than labor or active involvement in an enterprise.
Gilead Sciences: 2024 Catalysts Should Drive Growth And Change In Sentiment
10:06pm, Thursday, 15'th Feb 2024
Gilead Sciences: 2024 Catalysts Should Drive Growth And Change In Sentiment
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials
06:45pm, Thursday, 15'th Feb 2024
Gilead Sciences said on Thursday enrollments to test its cancer drug, magrolimab, on solid tumors had been paused globally, a week after the U.S. regulator put some studies on hold following increased
Gene therapy: Why does it cost millions for a single treatment?
07:01am, Thursday, 15'th Feb 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the medic
Where Are Biotech ETFs Headed After Q4 Earnings?
05:51pm, Wednesday, 14'th Feb 2024
Look into how Biotech ETFs performed after Q4 earnings.
Gilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline
10:26am, Tuesday, 13'th Feb 2024
Gilead (GILD) is all set to acquire CymaBay Therapeutics for $4.3 billion and strengthen its liver disease portfolio with the addition of seladelpar to its pipeline.
Why Gilead Sciences Is Buying CymaBay Therapeutics for $4.3 Billion
01:55pm, Monday, 12'th Feb 2024
Shares of CymaBay Therapeutics (CBAY) soared to an all-time high Monday after Gilead Sciences (GILD) announced it's buying the developer of medicine for liver and other chronic diseases for $4.3 billi
